This could have translational relevance, as one recent study showed SIRT2 expression to be significantly lower in peripheral T-lymphocytes of breast cancer patients, which suggested insufficient antitumor immunity due to compromised detection of tumor cells [39]. This evidence concerns the gene SIRT2 and breast carcinoma.